Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2010
12/08/2010EP1480674B1 Treatment of central nervous system damage
12/08/2010EP1458759B1 Human antibodies against human glycoprotein vi and their use
12/08/2010EP1455821B1 Parathyroid hormone antibodies and related methods
12/08/2010EP1443958B1 Vaccine against infectious disease
12/08/2010EP1427750B1 Modified transferrin fusion proteins
12/08/2010EP1395284B1 Non-depleting anti-CD4 antibody TRX1 and its uses
12/08/2010EP1389997B1 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
12/08/2010EP1082341B1 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
12/08/2010EP0826041B1 Transforming growth factor alpha hii
12/08/2010EP0772619B2 Immunomodulatory oligonucleotides
12/08/2010CN1893973B Methods for porducing storage stable viruses and immunogenic compositions thereof
12/08/2010CN1749397B Bi-recombinant active carrier vaccine of co-expression pig gyrate virus and foot and mouth disease virus
12/08/2010CN1384884B Herpes virus vectors for dendritic cells
12/08/2010CN101910201A B-cell depleting agents, like anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome
12/08/2010CN101910200A Improved NOGO-A binding molecules and pharmaceutical use thereof
12/08/2010CN101909693A Combination of anti-CTLA4 antibody with tubulin modulating agents for the treatment of proliferative diseases
12/08/2010CN101909655A Method of delivering an anti-cancer agent to a cell
12/08/2010CN101909648A Compositions and methods for treating inflammation
12/08/2010CN101909647A Use of TrkB antibodies for the treatment of respiratory disorders
12/08/2010CN101909646A Allergy vaccine composition for mucosal administration
12/08/2010CN101909635A Novel vaccines against multiple subtypes of dengue virus
12/08/2010CN101909611A Compositions and methods for enhancing immune response
12/08/2010CN101906464A Proteins producing an altered immunogenic response and methods of making and using the same
12/08/2010CN101906404A Avian infectious bronchitis virus (IBV) as well as culture method and application thereof
12/08/2010CN101906403A Enterovirus and application thereof
12/08/2010CN101906395A Transformant for blocking chicken myostatin effect by oral immunity and application thereof
12/08/2010CN101906166A Streptococcus recombination subunit vaccine and preparation method
12/08/2010CN101906164A Coupled protein
12/08/2010CN101906163A Immunocontraceptive synthetic peptide and immunocontraceptive chimeric peptide and application thereof
12/08/2010CN101905024A Composition comprising and method of using angiopoietin-like protein 3 ANGPTl3
12/08/2010CN101905022A Stable medicinal composition containing artemisia pollen allergen and preparation method thereof
12/08/2010CN101905021A Trigeminal live vaccine of canine distemper viruses, canine parvoviruses and Type I canine adenoviruses and preparation method thereof
12/08/2010CN101905020A Method for producing swine fever vaccines
12/08/2010CN101905019A Porcine hemagglutinating encephalomyelitis cell culture inactivated vaccine and preparation method thereof
12/08/2010CN101905018A Recombinant fusion protein vaccine and attenuated live vector vaccine for treating and preventing helicobacter pylori (Hp) infection
12/08/2010CN101904870A Anti-swine flu transfer factors
12/08/2010CN101597595B Bi-functional monoclonal antibody capable of anti-human von willbrand factor-A3
12/08/2010CN101440359B Avian influenza viral vaccine and preparation thereof
12/08/2010CN101422605B Immunoloregulation type DNA vaccine capable of preventing Eimeria necatrix
12/08/2010CN101386832B Recombinant bacterium of brucella melitensis and use thereof
12/08/2010CN101376880B Recombinant new castle disease LaSota attenuated vaccine strain expressing rabies virus glucoprotein (GP protein)
12/08/2010CN101293099B Polypeptide vaccine for resisting multiple hypotype avian influenza viruses and preparation method thereof
12/08/2010CN101210050B Antibodies for preventing bloodvessel endothelium growth factor
12/08/2010CN101041907B Compound for Fab fragment of Rituximab and CD20 antigen epitope polypeptide
12/07/2010US7848487 Methods for sterilizing biological materials containing non-aqueous solvents
12/07/2010US7847119 Drug conjugates
12/07/2010US7847085 Recombinant HIV-1 gp120 immunogen with three different V3 loops from viruses of different clades
12/07/2010US7847084 VMP-like sequences of pathogenic Borrelia species and strains
12/07/2010US7847082 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
12/07/2010US7847079 Albumin fusion proteins
12/07/2010US7847068 Neutralizing human anti-IGFR antibody
12/07/2010US7846726 Human fetal bladder-derived epithelial cells
12/07/2010US7846685 Methods and compositions for the control of coccidiosis
12/07/2010US7846675 Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains karp, kato and gilliam and its use in antibody based detection assays and vaccines
12/07/2010US7846672 Method for detecting the affinity of folate receptor auto antibodies
12/07/2010US7846655 Diagnosing respiratory system infections via presence presence of viral RNA sequences; enzyme inhibitors; viricides
12/07/2010US7846651 Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same
12/07/2010US7846479 poly(alpha-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, or a polycyanoacrylate, formed using detergents; biologically active macromolecule adsorbed on surface
12/07/2010US7846458 Method and vaccine for treatment of pythiosis insidiosi in humans and lower animals
12/07/2010US7846457 Cosmetic use of botulinum toxin for the treatment of eyebrow and forehead ptosis, and unwanted eyebrow expression
12/07/2010US7846456 treating a mammary gland disorder, including hyperplastic, hypertonic, cystic and/or neoplastic mammary gland tissue by local administration of a botulinum toxin to or to the vicinity of the afflicted breast tissue
12/07/2010US7846455 Major nucleocapsid protein, nucleocapsid phosphoprotein,large polymerase protein, a m2 (orf1) rna polymerase elongation factor, and a rsv genome or antigenome of human rsv strain or subgroup virus combined with a heterologous gene
12/07/2010US7846454 nucleotide sequences which encode infectious hepatitis C viruses, for development of vaccines and diagnostics for HCV and in the development of screening assays for the identification of antiviral agents for HCV
12/07/2010US7846453 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3
12/07/2010US7846451 Chimeric outermembrane polypeptide for use as tool in diagnosis and treatment of parasitic infection
12/07/2010US7846450 Glycoprotein-100 peptide for use as tool in treatment and diagnosis of cancer and viral infection
12/07/2010US7846449 Modified Dermatophagoides pteronyssinus allergen Der p 5 protein which inhibits immunoglobulin E (IgE) binding when exposed again to the antigen; treating allergies
12/07/2010US7846448 Lolium perenne (Lol p 1) polypeptide for use as diagnostic/prognostic indicator or allergic reactions
12/07/2010US7846447 Treating warts or verrucae that are induced by papillomavirus; killed mumps virus, candida or trichophyton extract; cytokines or colony stimulating factor
12/07/2010US7846446 Polypeptide comprising matriptase domain for use in treatment and prevention of ovarian cell proliferative disorders
12/07/2010US7846445 Increasing serum secretion half-life of a protein via variation in amino and/or carboxy terminals
12/07/2010US7846444 treating interleukin-22 (IL-22)-associated disorder such as arthritis or psoriasis by administering the antibody in an amount sufficient to inhibit or reduce immune cell activity in the subject
12/07/2010US7846443 Antibodies to IL-17A
12/07/2010US7846442 Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate
12/07/2010US7846441 Treatment with anti-ErbB2 antibodies
12/07/2010US7846440 Antibodies against ErbB3 and uses thereof
12/07/2010US7846439 Domain antibody construct
12/07/2010US7846438 Methods of promoting neurite outgrowth with soluble TAJ polypeptides
12/07/2010US7846437 Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same
12/07/2010US7846435 Humanized antibodies that recognize Verotoxin II and cell line producing same
12/07/2010US7846434 Materials and methods for improved immunoglycoproteins
12/07/2010US7846433 Methods of treating pre-eclampsia and eclampsia
12/07/2010US7846432 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
12/07/2010US7846420 Antigen or attenuated or killed mycobacterium
12/07/2010CA2560221C Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders
12/07/2010CA2417570C Tumor-specific t cell activation by peptide antigens
12/07/2010CA2323576C Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines
12/07/2010CA2264925C Purification of antigen-specific t cells
12/07/2010CA2256543C Methods and compositions useful for inhibition of angiogenesis
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010138955A2 Methods and compositions for treating neoplasia
12/02/2010WO2010138939A1 CARDIOVASCULAR RELATED USES OF IL-1ß ANTIBODIES AND BINDING FRAGMENTS THEREOF
12/02/2010WO2010138885A2 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
12/02/2010WO2010138839A2 Use of 2 anti-sparc antibodies to predict response to chemotherapy
12/02/2010WO2010138803A2 Herv-k antigens, antibodies, and methods
12/02/2010WO2010138769A1 Amino acid sequences which enhance peptide conjugate solubility
12/02/2010WO2010138725A1 Treatment of pancreatic cancer using a dr5 agonist in combination with gemcitabine
12/02/2010WO2010138675A1 Simian adenovirus 41 and uses thereof
12/02/2010WO2010138621A2 Diagnosing and treating iga nephropathy
12/02/2010WO2010138610A2 Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease
1 ... 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 ... 1823